Agilon Health Stock Performance
| AGL Stock | USD 2.11 0.06 2.93% |
The firm shows a Beta (market volatility) of 3.14, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Agilon Health will likely underperform. At this point, agilon health has a negative expected return of -0.62%. Please make sure to confirm Agilon Health's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if agilon health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days agilon health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return 2.93 | Five Day Return 18.54 | Year To Date Return (83.68) | Ten Year Return (93.19) | All Time Return (93.19) |
1 | Disposition of 18750 shares by Benjamin Shaker of Agilon Health at 17.9976 subject to Rule 16b-3 | 09/10/2024 |
2 | AGL Energy Hasnt Managed To Accelerate Its Returns | 09/11/2024 |
3 | AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL Kahn Swick Foti, LLC Investigates the Officers and Directors of agilon health, inc. -... | 10/11/2024 |
4 | agilon health Trading Down 6.3 percent Should You Sell | 10/29/2024 |
5 | Agilon Health Inc Q3 2024 Earnings Report Preview What To Look For | 11/06/2024 |
6 | agilon health Reports Third Quarter 2024 Results | 11/07/2024 |
7 | Agilon Health Inc Q3 2024 Earnings Call Highlights Revenue Surge Amidst Margin Challenges | 11/08/2024 |
8 | Agilon Health stock target cut, hold rating on EBITDA miss | 11/11/2024 |
9 | agilon health Reports ACO REACH Model Results for 2023 Performance Year | 11/12/2024 |
10 | Leerink Partnrs Lowers Earnings Estimates for agilon health | 11/13/2024 |
11 | Agilon Healths SWOT analysis stock faces challenges amid value-based care growth | 11/25/2024 |
| Begin Period Cash Flow | 475.9 M |
Agilon |
Agilon Health Relative Risk vs. Return Landscape
If you would invest 385.00 in agilon health on August 31, 2024 and sell it today you would lose (174.00) from holding agilon health or give up 45.19% of portfolio value over 90 days. agilon health is generating negative expected returns assuming volatility of 7.8659% on return distribution over 90 days investment horizon. In other words, 70% of stocks are less volatile than Agilon, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Agilon Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Agilon Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as agilon health, and traders can use it to determine the average amount a Agilon Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0791
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AGL |
Estimated Market Risk
| 7.87 actual daily | 70 70% of assets are less volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Agilon Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Agilon Health by adding Agilon Health to a well-diversified portfolio.
Agilon Health Fundamentals Growth
Agilon Stock prices reflect investors' perceptions of the future prospects and financial health of Agilon Health, and Agilon Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Agilon Stock performance.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.0984 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 520.33 M | ||||
| Shares Outstanding | 412.02 M | ||||
| Price To Earning | 23.14 X | ||||
| Price To Book | 1.51 X | ||||
| Price To Sales | 0.16 X | ||||
| Revenue | 4.32 B | ||||
| Gross Profit | 112.29 M | ||||
| EBITDA | (167.64 M) | ||||
| Net Income | (262.8 M) | ||||
| Cash And Equivalents | 497.07 M | ||||
| Cash Per Share | 2.32 X | ||||
| Total Debt | 52.31 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.65 X | ||||
| Book Value Per Share | 1.40 X | ||||
| Cash Flow From Operations | (156.2 M) | ||||
| Earnings Per Share | (0.76) X | ||||
| Market Capitalization | 869.36 M | ||||
| Total Asset | 1.74 B | ||||
| Retained Earnings | (1.33 B) | ||||
| Working Capital | 502.92 M | ||||
| Current Asset | 1.54 B | ||||
| Current Liabilities | 2.49 B | ||||
About Agilon Health Performance
By examining Agilon Health's fundamental ratios, stakeholders can obtain critical insights into Agilon Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Agilon Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 1.34 | 1.41 | |
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Capital Employed | (0.30) | (0.32) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.40) | (0.38) |
Things to note about agilon health performance evaluation
Checking the ongoing alerts about Agilon Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for agilon health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| agilon health generated a negative expected return over the last 90 days | |
| agilon health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 4.32 B. Reported Net Loss for the year was (262.8 M) with profit before taxes, overhead, and interest of 112.29 M. | |
| agilon health has about 497.07 M in cash with (156.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| agilon health has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Agilon Healths SWOT analysis stock faces challenges amid value-based care growth |
- Analyzing Agilon Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Agilon Health's stock is overvalued or undervalued compared to its peers.
- Examining Agilon Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Agilon Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Agilon Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Agilon Health's stock. These opinions can provide insight into Agilon Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.951 | Earnings Share (0.76) | Revenue Per Share 13.717 | Quarterly Revenue Growth 0.276 | Return On Assets (0.1) |
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.